Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

NCT01494402 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence Study

Interventions

DRUG: D961S
DRUG: Esomeprazole
DRUG: Buffered acetylsalicylic acid

Sponsor

AstraZeneca